The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Kivu Bioscience Inc.
Neonc Technologies, Inc.
AstraZeneca
Radiopharm Theranostics, Ltd
MacroGenics
SystImmune Inc.
Radiopharm Theranostics, Ltd
VM Oncology, LLC
DualityBio Inc.
Janux Therapeutics
Sichuan Baili Pharmaceutical Co., Ltd.
University of Colorado, Denver
Marengo Therapeutics, Inc.
Cofactor Genomics, Inc.
Evopoint Biosciences Inc.